Cargando…

P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED

Detalles Bibliográficos
Autores principales: Al-Samkari, H., Morales-Arias, J., Xu, R., Beynon, V., Grace, R. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431126/
http://dx.doi.org/10.1097/01.HS9.0000849028.24492.c6
_version_ 1784779966609620992
author Al-Samkari, H.
Morales-Arias, J.
Xu, R.
Beynon, V.
Grace, R. F.
author_facet Al-Samkari, H.
Morales-Arias, J.
Xu, R.
Beynon, V.
Grace, R. F.
author_sort Al-Samkari, H.
collection PubMed
description
format Online
Article
Text
id pubmed-9431126
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94311262022-08-31 P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED Al-Samkari, H. Morales-Arias, J. Xu, R. Beynon, V. Grace, R. F. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431126/ http://dx.doi.org/10.1097/01.HS9.0000849028.24492.c6 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Al-Samkari, H.
Morales-Arias, J.
Xu, R.
Beynon, V.
Grace, R. F.
P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
title P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
title_full P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
title_fullStr P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
title_full_unstemmed P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
title_short P1543: MITAPIVAT DECREASES THE NEED FOR TRANSFUSIONS SECONDARY TO POORLY TOLERATED ANEMIA AND ACUTE EVENTS COMPARED TO PLACEBO IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
title_sort p1543: mitapivat decreases the need for transfusions secondary to poorly tolerated anemia and acute events compared to placebo in patients with pyruvate kinase deficiency who are not regularly transfused
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431126/
http://dx.doi.org/10.1097/01.HS9.0000849028.24492.c6
work_keys_str_mv AT alsamkarih p1543mitapivatdecreasestheneedfortransfusionssecondarytopoorlytoleratedanemiaandacuteeventscomparedtoplaceboinpatientswithpyruvatekinasedeficiencywhoarenotregularlytransfused
AT moralesariasj p1543mitapivatdecreasestheneedfortransfusionssecondarytopoorlytoleratedanemiaandacuteeventscomparedtoplaceboinpatientswithpyruvatekinasedeficiencywhoarenotregularlytransfused
AT xur p1543mitapivatdecreasestheneedfortransfusionssecondarytopoorlytoleratedanemiaandacuteeventscomparedtoplaceboinpatientswithpyruvatekinasedeficiencywhoarenotregularlytransfused
AT beynonv p1543mitapivatdecreasestheneedfortransfusionssecondarytopoorlytoleratedanemiaandacuteeventscomparedtoplaceboinpatientswithpyruvatekinasedeficiencywhoarenotregularlytransfused
AT gracerf p1543mitapivatdecreasestheneedfortransfusionssecondarytopoorlytoleratedanemiaandacuteeventscomparedtoplaceboinpatientswithpyruvatekinasedeficiencywhoarenotregularlytransfused